Vanberra Signal
Free trial

Lexogen

Curated by Signal

Provider of kits and software that enable detailed analysis of the complete transcriptome

Life Sciences Technologylexogen.com

Overview

Lexogen has developed expression profiling methods that enable detailed analysis of the complete transcriptome as well as individual full-length RNAs of interest. Its product portfolio includes expression profiling library prep kits (for Illumina, Ion Torrent); Whole transcriptome library prep kits; kits for RNA isolation and cDNA amplification, and other for barcoding, PCR etc. Also provides software for RNA-Seq data analysis.

Key facts

Founded
2007
Headquarters
Vienna, Austria
Stage
Sign up to view
Industry
Life Sciences Technology

Business model

6 products and services
Sign up to view
Commercial model
Sign up to view

Contact

Email
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

  • Visiomics

    Online platform for liquid biopsies based multiomics analysis for tumor diagnostics

    Life Sciences TechnologyVienna, Austria

  • Ares Genetics

    Provider of DNA-based precision medicine for infectious diseases

    Life Sciences TechnologyVienna, Austria

  • Alpha Trace

    Diagnostics and monitoring systems for hospitals

    Life Sciences TechnologyVienna, Austria

About Lexogen

What does Lexogen do?

Lexogen has developed expression profiling methods that enable detailed analysis of the complete transcriptome as well as individual full-length RNAs of interest.

Where is Lexogen headquartered?

Lexogen is headquartered in Vienna, Austria.

When was Lexogen founded?

Lexogen was founded in 2007.

Which sector is Lexogen in?

Lexogen operates in Life Sciences Technology.

Who are Lexogen's competitors?

Companies similar to Lexogen include Visiomics, Ares Genetics, and Alpha Trace.